Literature DB >> 11488836

Bone mineral density of patients with chronic plaque psoriasis.

T P Millard1, L Antoniades, A V Evans, H R Smith, T D Spector, J N Barker.   

Abstract

Reduced bone mineral density (BMD), the major risk factor for osteoporotic fracture, has been linked to palmoplantar pustular psoriasis, but no significant studies have examined BMD in chronic plaque psoriasis (CPP). In this study, in-patients with severe CPP had their BMD measured at the nondominant hip and lumbar spine using dual energy X-ray absorbtiometry. Ten male and 10 female Caucasian patients were recruited, with a mean age of 47 years (range 20--71 years). There were no significant differences in BMD between patients and controls. However, patients with psoriatic arthropathy in addition to CPP had a significantly lower mean lumbar spine Z-score (- 1.16) than those without arthropathy (+1.38, P = 0.015). Neither previous nor current treatment with systemic steroids, retinoids or methotrexate significantly affected BMD. We found no evidence that patients with CPP, despite risk factors, have a significantly low BMD, although the subgroup with joint involvement appear be at significantly higher risk of osteoporosis and may therefore require preventative treatment.

Entities:  

Mesh:

Year:  2001        PMID: 11488836     DOI: 10.1046/j.1365-2230.2001.00855.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  13 in total

1.  Bone microstructure and volumetric bone mineral density in patients with hyperuricemia with and without psoriasis.

Authors:  D Simon; J Haschka; C Muschitz; A Kocijan; A Baierl; A Kleyer; G Schett; S Kapiotis; H Resch; M Sticherling; J Rech; R Kocijan
Journal:  Osteoporos Int       Date:  2020-01-10       Impact factor: 4.507

2.  Association between osteoporosis and psoriasis: results from the Longitudinal Health Insurance Database in Taiwan.

Authors:  J J Keller; J-H Kang; H-C Lin
Journal:  Osteoporos Int       Date:  2012-10-07       Impact factor: 4.507

3.  Osteoporosis in psoriatic arthritis: is there any?

Authors:  Simeon Grazio; Selma Cvijetić; Tonko Vlak; Frane Grubišić; Valentina Matijević; Tomislav Nemčić; Marija Punda; Zvonko Kusić
Journal:  Wien Klin Wochenschr       Date:  2011-11-29       Impact factor: 1.704

Review 4.  Impact of Chronic Inflammation in Psoriasis on Bone Metabolism.

Authors:  Anja Saalbach; Manfred Kunz
Journal:  Front Immunol       Date:  2022-06-23       Impact factor: 8.786

5.  Bone mineral density and bone turnover in patients with psoriatic arthritis.

Authors:  Pinar Borman; Seçil Babaoğlu; Guneş Gur; Sezin Bingol; Hatice Bodur
Journal:  Clin Rheumatol       Date:  2007-09-18       Impact factor: 2.980

6.  Evaluation of osteoporosis in hemophilic arthropathy patients: correlation with disease severity and serum trace minerals.

Authors:  Eiman Mahmoud Ghaniema; Sahar Fathi Ahmed; Irene Raouf Amin; Maryse Soliman Ayoub
Journal:  J Osteoporos       Date:  2011-10-05

7.  Bone mineral density and body composition in postmenopausal women with psoriasis and psoriatic arthritis.

Authors:  Paulo G Pedreira; Marcelo M Pinheiro; Vera L Szejnfeld
Journal:  Arthritis Res Ther       Date:  2011-02-07       Impact factor: 5.156

Review 8.  Psoriasis: classical and emerging comorbidities.

Authors:  Maria de Fátima Santos Paim de Oliveira; Bruno de Oliveira Rocha; Gleison Vieira Duarte
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

9.  A Florid Case of Iatrogenic Cushing's Syndrome Induced by Topical Steroid with Osteoporosis and Hypogonadism.

Authors:  Pranab Kumar Sahana; Nilendu Sarma; Nilanjan Sengupta; Prashant Subhash Somani
Journal:  Indian J Dermatol       Date:  2015 Jul-Aug       Impact factor: 1.494

10.  Systemic side-effects of topical corticosteroids.

Authors:  Sandipan Dhar; Joly Seth; Deepak Parikh
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.